Navigation Links
Medimetriks Pharmaceuticals Launches Two New Prescription Brands
Date:4/27/2009

s.com/" target="_new">www.medimetriks.com

About Medimetriks Pharmaceuticals, Inc.

Medimetriks Pharmaceuticals develops, licenses and commercializes prescription skincare products primarily for the Dermatology and Podiatry marketplaces. The Company's mission is to enhance patient quality-of-life by providing innovative therapies that advance patient care.

The Company is located at 363 Route 46 West, Fairfield, NJ 07004-2402. Please visit the Medimetriks website at www.medimetriks.com, call (973) 882-7512 or fax (973) 882-7502.


'/>"/>
SOURCE Medimetriks Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Perrigo Company Appointed Generic Distributor by Medimetriks Pharmaceuticals
2. Medimetriks Pharmaceuticals Launches Companys First Prescription Brands
3. Perrigo Company Licenses Prescription Brands to Medimetriks Pharmaceuticals
4. PUR Water Filtration Systems Can Reduce Trace Levels of Pharmaceuticals Found in Some U.S. Tap Water
5. Valeant Pharmaceuticals Highlights Taribavirin Phase IIb 60-Week Data Presentation at European Association for the Study of Liver (EASL) Annual Meeting
6. Vion Pharmaceuticals Receives a Standard Review from the FDA for Its New Drug Application for Onrigin(TM)
7. Valeant Pharmaceuticals to Announce 2009 First Quarter Results on May 5, 2009
8. Genesis Pharmaceuticals Changes its Name to Jiangbo Pharmaceuticals, Inc. to Reflect its Brand Name
9. Lotus Pharmaceuticals, Inc. Reports Strong 2008 Financial Results
10. Genesis Pharmaceuticals Announces the Launch of Three TCM Products
11. Celator(R) Pharmaceuticals Presents New Data on CPX-351 And CPX-1 at the American Association for Cancer Research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ire/--WhenmostpeopleheartheacronymTMJ,theythinkoft...helptheyneed.TMJstandsfortheTemporal-MandibularJoi...ithyourskull(temporalbone). ,, Themostcommonsym...g,clickingorpoppingofthejaw.Butmanyothersymptomsca...igue,sleepdisturbances,irritability,alossinfocus,r...
(Date:11/25/2009)...MedicalInc.,aleadingmanufacturerofbreastMRIcoilsan...eadingedgeclinicalapplicationsonitsAegis(TM)medica...cietyofNorthAmerica(RSNA)annualmeetinginChicago,No...veragetheuniquehighqualityimagesgeneratedbySentine...magingmodalitiesformulti-parametricassessment. ,...
(Date:11/25/2009)...ayAreaAirQualityManagementDistrictisissuingtheseas... forThursday,November26,2009whichbansburningwood,m...andoutdoors. ,, "Cold,stillweatherwillcontribut...executiveofficeroftheAirDistrict."We,reaskingBayAr...llowcommunitymembersthisThanksgiving,andnottoburnw...
(Date:11/25/2009)... collaboration between UCLA engineers and physicia...illion Americans who suffer from peripheral arteri... arteries, peripheral arterial disease, or PAD, is...teries reduce blood flow to the limbs. The conditi...heart attack and stroke, and its progression can r...
(Date:11/25/2009)...tment clinics to resume Monday, Nov. 30 , ...09 -- Centegra Health System is continuing to offe...ur Centegra Primary Care (CPC) vaccination clinics...e clinics are at CPC sites in Huntley, Woodstock, ...ws: ,   From 4:30 to 7:30 p.m. Tuesday...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
...ts , , FRIDAY, Nov. 21 (HealthDay News) -...at child,s risk of asthma, new research suggests. ...e the peak of winter virus season -- have almost a...Journal of Respiratory and Critical Care Medicine ...
... are not given adequate drug therapy. This is the ...dition of Deutsches rzteblatt International ( Dt...r et al. present the German results of this prospe...cardiovascular diseases and 10.8% only exhibited r...
...oration (NYSE: HUN ) today announced that its Fo...r Americans chosen by the American Cancer Society ... honor. Given annually, the,award is reserved for...or,personally contributed over $600 million to the...
...utual Life,Insurance Company (MassMutual) today an...ng Officers. , -- Roger W. Crandall, Co-Chie...Chief Investment Officer, will assume the position...Operating Officer,and join the company,s Board of ...
...Inc.,( http://www.cardiosolutionsinc.com ) has ann... Ph.D. to the position of Chief Surgical Officer. ...er for Aortic Surgery and Director of the,Marfan S...c. is developing its proprietary Percu-Pro(TM) Sys...
...ocated in,Pittsburgh PA, and a subsidiary of Draeg...ountering what it believes are unsubstantiated all...formerly Bacou-Dalloz USA) of a patent,infringemen... property rights, but,believes that this lawsuit i...
Other Medicine News:Health News:Autumn Babies More Prone to Asthma 2Health News:Autumn Babies More Prone to Asthma 3Health News:Jon M. Huntsman Receives American Cancer Society Medal of Honor 2Health News:MassMutual Announces Promotions for Two Co-Chief Operating Officers 2Health News:MassMutual Announces Promotions for Two Co-Chief Operating Officers 3Health News:MassMutual Announces Promotions for Two Co-Chief Operating Officers 4Health News:MassMutual Announces Promotions for Two Co-Chief Operating Officers 5Health News:Cardiosolutions Names Dr. Lars Svensson Chief Surgical Officer 2Health News:Draeger Counters What It Believes Are Unsubstantiated Allegations of Patent Infringement by Sperian 2
(Date:11/25/2009)..., SANDIEGO,Nov.25/PRNewswire-FirstCall/--NuVasi...dondevelopingproductsforminimallydisruptivesurgica...taconferencecallonMonday,November30,2009,at5:30p.m...issuesrelativetoreimbursementfortheCompany,sproduc...hortquestionandanswersession.Thedial-innumbersare1...
(Date:11/25/2009)..., NEWYORK,Nov.25/PRNewswire/--Reportlinker.coma...tscatalogue: ,, IntranasalDrugDelivery-USMarke...p0164267/Intranasal-Drug-Delivery---US-Market-Tren...rymarketiswitnessinganexpansionoftherapeuticapplic...cdrugstothedeliveryofsystemictherapeuticdrugs.Thef...
(Date:11/25/2009)..., MOUNTAINVIEW,Calif.,Nov.25/PRNewswire/-- Che...aldatafromtheCompany,sPROTECT-1(theProspectiveRand...fTraficet-EN(TM)(CCX282-B)inpatientswithmoderate-t...withafavorablesafetyandtolerabilityprofile.Thestud...ionofdiseaseseverityasdefinedasa70-pointdecreasein...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5OxySure 28R 29 Aids Student in School Respiratory Arrest 3A WFAA Channel 8 News 5835 1OxySure 28R 29 Aids Student in School Respiratory Arrest 3A WFAA Channel 8 News 5835 2OxySure 28R 29 Aids Student in School Respiratory Arrest 3A WFAA Channel 8 News 5835 3Burton Medicals New Diagnostic Examination Light the AIM LED Provides 10 Percent More Illumination and 10 Times Greater Lamp Life 5833 1Burton Medicals New Diagnostic Examination Light the AIM LED Provides 10 Percent More Illumination and 10 Times Greater Lamp Life 5833 2Rogan Delft Approves Matrox Xenia Series for Use With Zillion Suite 5831 1Rogan Delft Approves Matrox Xenia Series for Use With Zillion Suite 5831 2Rogan Delft Approves Matrox Xenia Series for Use With Zillion Suite 5831 3
...SynergEyes, Inc., the high Dk hybrid contact lens ... million in Series C financing to fund the develop...d contact lens products and to expand sales and ma...f Palo Alto, CA, led this round as well as SynergE...joined Series A and B investors: Alloy Ventures, D...
...e of Cardiology publishes positive ATLAS clinical ... Corporation (NYSE: BSX ) today announced that i...ration (FDA) the final modules of the Company,s Pr...TAXUS(R) Liberte(R) Atom(TM) Paclitaxel-Eluting Co... Paclitaxel-Eluting Coronary Stent System. If app...
Other Medicine Technology:SynergEyes, Inc. Raises $13.3 Million in 'Series C' Financing 2Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents 2Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents 3Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents 4Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents 5
Basic modular VICTOR2 Multilabel Counter (3 technologies)
VICTOR2 V (5 technologies), manual model
VICTOR2 multilabel counter with stacker and robot loading
... 96-channel parallel detection of fluorescence, ab...l microtiter plates. Compact workstations and sys...ansport of microtiter plates with a throughput of ... switching required by numerous other systems to s...
Medicine Products: